BThe AI correction now has a name: Anthropic.
BThe lab behind Claude?
BReuters posted on X: "AI backlash could threaten Anthropic IPO timing, potential investors say."
BSo the would-be investors are telling Reuters they're nervous.
BRight. No final delay, but the timing and valuation are suddenly harder to sell.
BNot exactly shocking. AI sentiment turned fast.
BYou've had a brutal tech selloff, and AI names are taking the hit.
BAnd the AI backlash isn't just online. Regulators are circling, too.
BThat's exactly my point. Anthropic is a serious company, not some vaporware app.
BThen it should be able to wait.
BWait? This is the moment capital is most expensive. If you can't IPO now, you may not get a better window.
BBut going public into a market that hates AI would be worse.
BNo, no— markets price risk. A bad debut can still leave the company with cash to build.
BIt leaves retail investors holding the bag if sentiment doesn't recover.
BOh, come on. That's not what they're deciding.
BIt's part of the calculus. You don't list a company to prove a point; you list to raise money at a good price.
BAnd waiting could mean a year of expensive private funding, maybe worse terms.
BSo the investor complaints are a negotiating tactic.
BMaybe. They're saying, "fix your valuation, or we're not buying."
BThat sounds healthy. The AI premiums were insane.
BSome were. Anthropic has real revenue, real customers. Claude is used by major companies.
B"Claude is used" doesn't tell me it's profitable.
BNeither was Amazon for years. The question is whether the growth story is intact.
BAnthropic's growth is tied to models that cost a fortune to train.
BBut the AI backlash could actually help. Companies want smaller, cheaper models.
BThat's a pivot, not a recovery.
BWe keep moving the goalposts. Is the IPO threatened or isn't it?
BThe report says investors think it could be. Nothing final.
BRight. So this is a warning shot.
BA warning shot from people who want a lower price.
BAnd from a market that has punished AI names all week.
BI'm not saying the company is doomed. I'm saying the IPO timing was always fragile.
BBut that's exactly why a delay would be a mistake. You don't let a bad narrative set your timeline.
BYou also don't rush into a market that's pricing in more regulation and less hype.
BThe best companies list in bad markets. The worst list when everything is perfect.
BThat's a nice line. It's also survivorship bias.
BFine. It's a little bit survivorship bias.
BBut there's a real question here: does the retail investor even need another AI IPO?
BIf it's a serious competitor to the big labs, yes. More competition is better.
BCompetition can happen without every company being public.
BBut public markets force discipline. That's good for the sector.
BDiscipline? You just argued they should IPO into chaos.
BI argued they shouldn't be scared out of it by a few jittery investors.
BAnd I think jittery investors are exactly the people who should set the price.
BGreat. So the market is right when it agrees with you.
BNo— the market is a signal. You can hate the signal and still respect it.
BI do respect it. I just don't want Anthropic to miss a window based on an AI panic that could fade.
BOr the panic could be the start of a normal correction.
BEither way, no delay has been announced. So we watch.
BWe watch, and we argue.